BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29515203)

  • 1. Natural polyphenols as sirtuin 6 modulators.
    Rahnasto-Rilla M; Tyni J; Huovinen M; Jarho E; Kulikowicz T; Ravichandran S; A Bohr V; Ferrucci L; Lahtela-Kakkonen M; Moaddel R
    Sci Rep; 2018 Mar; 8(1):4163. PubMed ID: 29515203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer's Disease, Aging, Cancer, Inflammation, and Diabetes.
    Akter R; Afrose A; Rahman MR; Chowdhury R; Nirzhor SSR; Khan RI; Kabir MT
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin based derivatives as sirtuin inhibitors.
    Heger V; Tyni J; Hunyadi A; Horáková L; Lahtela-Kakkonen M; Rahnasto-Rilla M
    Biomed Pharmacother; 2019 Mar; 111():1326-1333. PubMed ID: 30841446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities.
    Rahnasto-Rilla M; Järvenpää J; Huovinen M; Schroderus AM; Ihantola EL; Küblbeck J; Khadeer M; Moaddel R; Lahtela-Kakkonen M
    Biomed Pharmacother; 2020 Nov; 131():110701. PubMed ID: 32905943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells.
    Tenhunen J; Kučera T; Huovinen M; Küblbeck J; Bisenieks E; Vigante B; Ogle Z; Duburs G; Doležal M; Moaddel R; Lahtela-Kakkonen M; Rahnasto-Rilla M
    Biomed Pharmacother; 2021 Jun; 138():111452. PubMed ID: 33684691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives.
    You W; Zheng W; Weiss S; Chua KF; Steegborn C
    Sci Rep; 2019 Dec; 9(1):19176. PubMed ID: 31844103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of activation for the sirtuin 6 protein deacylase.
    Klein MA; Liu C; Kuznetsov VI; Feltenberger JB; Tang W; Denu JM
    J Biol Chem; 2020 Jan; 295(5):1385-1399. PubMed ID: 31822559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.
    Klein MA; Denu JM
    J Biol Chem; 2020 Aug; 295(32):11021-11041. PubMed ID: 32518153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
    You W; Steegborn C
    J Med Chem; 2018 Dec; 61(23):10922-10928. PubMed ID: 30395713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitro-fatty acids as activators of hSIRT6 deacetylase activity.
    Carreño M; Bresque M; Machado MR; Santos L; Durán R; Vitturi DA; Escande C; Denicola A
    J Biol Chem; 2020 Dec; 295(52):18355-18366. PubMed ID: 33122195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and biochemical functions of SIRT6.
    Pan PW; Feldman JL; Devries MK; Dong A; Edwards AM; Denu JM
    J Biol Chem; 2011 Apr; 286(16):14575-87. PubMed ID: 21362626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insight into the Interactions between Structurally Similar Inhibitors and SIRT6.
    Zhao S; Zhu YY; Wang XY; Liu YS; Sun YX; Zhao QJ; Li HY
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel and selective SIRT6 inhibitors.
    Parenti MD; Grozio A; Bauer I; Galeno L; Damonte P; Millo E; Sociali G; Franceschi C; Ballestrero A; Bruzzone S; Del Rio A; Nencioni A
    J Med Chem; 2014 Jun; 57(11):4796-804. PubMed ID: 24785705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography.
    Singh N; Ravichandran S; Norton DD; Fugmann SD; Moaddel R
    Anal Biochem; 2013 May; 436(2):78-83. PubMed ID: 23376017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Therapeutic Potential of SIRT6 Modulators.
    Fiorentino F; Mai A; Rotili D
    J Med Chem; 2021 Jul; 64(14):9732-9758. PubMed ID: 34213345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of quercetin on the protein-substrate interactions in SIRT6: Insight from MD simulations.
    Zhang H; Zhang J; Zhang HX
    J Mol Graph Model; 2024 Jul; 130():108778. PubMed ID: 38652998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.
    You W; Rotili D; Li TM; Kambach C; Meleshin M; Schutkowski M; Chua KF; Mai A; Steegborn C
    Angew Chem Int Ed Engl; 2017 Jan; 56(4):1007-1011. PubMed ID: 27990725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules.
    Sociali G; Liessi N; Grozio A; Caffa I; Parenti MD; Ravera S; Tasso B; Benzi A; Nencioni A; Del Rio A; Robina I; Millo E; Bruzzone S
    Mol Divers; 2020 Aug; 24(3):655-671. PubMed ID: 31240519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
    Sun W; Chen X; Huang S; Li W; Tian C; Yang S; Li L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127215. PubMed ID: 32631504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin modulators.
    Mahajan SS; Leko V; Simon JA; Bedalov A
    Handb Exp Pharmacol; 2011; 206():241-55. PubMed ID: 21879453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.